• Home
  • About CHERISH
    • Mission
    • Team
    • Advisory Boards
    • Research Affiliates
    • Careers
  • What We Do
    • Overview
    • Economic Evaluation Methods
    • Population Data
    • Simulation Modeling
    • Dissemination Science
    • Consultation Service
    • Mentoring
    • Training
  • Pilot Grants
    • Overview
    • Funded Pilots
  • Tools & Resources
    • Overview
    • Instruments & Measures
    • Unit Costs
    • Budget Impact Tools
    • Learning Modules
    • Policy Briefs
    • Literature Reviews
    • Language for Substance Use
    • Further Readings
  • News & Events
    • News
    • Events
    • Newsletters
  • Contact Us
Skip to main content
  • About CHERISH
    • Mission
    • Team
    • Advisory Boards
    • Research Affiliates
    • Careers
  • What We Do
    • Overview
    • Economic Evaluation Methods
    • Population Data
    • Simulation Modeling
    • Dissemination Science
    • Consultation Service
    • Mentoring
    • Training
  • Pilot Grants
    • Overview
    • Funded Pilots
  • Tools & Resources
    • Overview
    • Instruments & Measures
    • Unit Costs
    • Budget Impact Tools
    • Learning Modules
    • Policy Briefs
    • Literature Reviews
    • Language for Substance Use
    • Further Reading
  • News & Events
    • News
    • Events
    • Newsletters
  • Contact Us
Pilot Grants Funded Pilots

HIV

Cycle 11 (2025-2026)

Evaluating the Cost-Effectiveness of Scaling Long-Acting Injectable PrEP Among PWID: The Role of Uptake and Population Characteristics

Cycle 10 (2024-2025)

Cost Analysis for a Retail Mobile Community Pharmacy Addressing Substance Use and HIV Prevention Services in Underserved Communities

Cycle 9 (2023-2024)

U.S. Health Care Spending on HIV, HCV and Substance Use Care from 2010 to 2019: Variation by Area and Demographics

Cycle 8 (2022-2023)

Characterizing Injectable HIV PrEP Implementation in Family Medicine

Cycle 8 (2022-2023)

An Economic Analysis of Factors Associated with Preexposure Prophylaxis (PrEP) for HIV Prevention Use Among Women

Cycle 4 (2018-2019)

Simplification of hepatitis C care: changes in the provider landscape after direct-acting antivirals and their impact on treatment

  • Mission
  • Team
  • Careers
  • News
  • Events
  • Contact Us
  • Consultation
  • Pilot Grants
  • Mentoring
  • Training
  • Instruments & Measures
  • Unit Costs
  • Budget Impact Tools
  • Learning Modules
  • Literature Reviews
  • Policy Briefs
  • Language for Substance Use Research
  • Further Reading
Follow Us

The Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) is funded by NIDA as a collaboration among Weill Cornell Medicine, Boston Medical Center, Boston University School of Public Health, University of Pennsylvania, and University of Miami Miller School of Medicine (P30DA040500).

All Materials ©2026 CHERISH. All Rights Reserved.